PrintThe Burrill Report
The Burrill Report - Sponsored Podcast (October 29, 2013): Customer Excellence: Business Model Innovation for MedTechs (.MP3,20.31 Mb)
Cost pressures on hospitals are changing the way they look at innovative products and forcing MedTech companies to rethink their offerings. In order to be competitive, companies today must provide comprehensive solutions that deliver clear value. We spoke to Jonas Funk, managing director with LEK Consulting in Chicago, about his recent report on business model innovation for MedTech companies, the changing environment in which hospitals are looking at medical technologies, and what MedTech companies will need to do to be successful.
Download LEK Consulting's report Customer Excellence: Business Model Innovation for MedTechs
October 29, 2013
http://www.burrillreport.com/article-customer_excellence_business_model_innovation_for_medtechs.html
SPONSORED CONTENT
Customer Excellence: Business Model Innovation for MedTechs
Podcast: October 29, 2013[Please login to post comments]
- Shire to Buy ViroPharma for $4.2B
Deal, the fourth acquisition for the company this year, boosts rare disease portfolio. Read More - Sarepta Plummets after FDA says NDA Filing for Eteplirsen Premature
The weekly roundup of failed trials, missed targets, and other business mishaps. Read More - Global Diabetes Pandemic Shows No Sign of Abating
A surge in the chronic condition hits every nation. Read More - FDA Gives OK for Imbruvica to Treat Rare Blood Cancer
Pharmacyclics’ and J&J;’s ibrutinib is second Breakthrough Therapy drug to gain approval. Read More - Life Sciences IPO Fever Cools
Tandem Diabetes Care and Relypsa go public, while several others postpone offerings. Read More - Immatics and Roche Sign Cancer Deal Worth Up to $1B
Strategic collaboration focuses on cancer vaccines and immunotherapies. Read More - Fixing a $30 Billion a Year
Healthcare Problem
Podcast: November 18, 2013 Read More - Salix to pay $2.6B for Santaris
Deal strengthens its GI focus and gives it new colitis drug. Read More - Robust Pace of Financings Continues
Companies raise $53B in first three quarters of 2013. Read More - New Senate Bill Could Be Boon to Biotechs
Start-up Jobs and Innovation Act would stimulate R&D; investment at emerging growth companies. Read More
.gif)
